Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.

@article{Irvine1999PoorAT,
  title={Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.},
  author={Jane Irvine and Bruce Baker and Juliana Smith and S Jandciu and Miney Paquette and James Cairns and S. Connolly and Rebecca S. Roberts and Michael J. Gent and P. Dorian},
  journal={Psychosomatic medicine},
  year={1999},
  volume={61 4},
  pages={
          566-75
        }
}
OBJECTIVE This study examined the relationship between adherence, mortality, and psychosocial factors. METHODS Subjects were 1141 patients participating in the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. Poor adherence to study medication (amiodarone or placebo), measured by pill count over 2 years, was defined as the lower 20th percentile of the pill count distribution. Predictors of adherence were also studied and included demographic and cardiac variables and, in a subset… CONTINUE READING

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 61 CITATIONS, ESTIMATED 42% COVERAGE

Accountability in patient adherence

VIEW 1 EXCERPT
CITES BACKGROUND

PPA_A_213113 1511..1517

VIEW 1 EXCERPT
CITES BACKGROUND

Self-reported Medication Adherence and CKD Progression

VIEW 1 EXCERPT
CITES RESULTS

FILTER CITATIONS BY YEAR

2002
2019

CITATION STATISTICS

  • 3 Highly Influenced Citations